- Home
- HFFG vs CERS Comparison
HFFG vs CERS Comparison
Compare HFFG & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- CERS
- Stock Information
- Founded
- HFFG 1997
- CERS 1991
- Country
- HFFG United States
- CERS United States
- Employees
- HFFG N/A
- CERS N/A
- Industry
- HFFG Food Distributors
- CERS EDP Services
- Sector
- HFFG Consumer Discretionary
- CERS Technology
- Exchange
- HFFG Nasdaq
- CERS Nasdaq
- Market Cap
- HFFG 208.3M
- CERS 237.7M
- IPO Year
- HFFG N/A
- CERS 1997
- Fundamental
- Price
- HFFG $3.69
- CERS $1.27
- Analyst Decision
- HFFG
- CERS Strong Buy
- Analyst Count
- HFFG 0
- CERS 2
- Target Price
- HFFG N/A
- CERS $3.50
- AVG Volume (30 Days)
- HFFG 96.7K
- CERS 1.2M
- Earning Date
- HFFG 08-11-2025
- CERS 08-05-2025
- Dividend Yield
- HFFG N/A
- CERS N/A
- EPS Growth
- HFFG N/A
- CERS N/A
- EPS
- HFFG N/A
- CERS N/A
- Revenue
- HFFG $1,216,952,000.00
- CERS $192,510,000.00
- Revenue This Year
- HFFG $4.27
- CERS $24.95
- Revenue Next Year
- HFFG $4.47
- CERS $11.88
- P/E Ratio
- HFFG N/A
- CERS N/A
- Revenue Growth
- HFFG 4.88
- CERS 13.25
- 52 Week Low
- HFFG $1.70
- CERS $1.12
- 52 Week High
- HFFG $4.93
- CERS $2.39
- Technical
- Relative Strength Index (RSI)
- HFFG 63.25
- CERS 47.80
- Support Level
- HFFG $3.42
- CERS $1.23
- Resistance Level
- HFFG $3.87
- CERS $1.38
- Average True Range (ATR)
- HFFG 0.24
- CERS 0.07
- MACD
- HFFG 0.08
- CERS -0.00
- Stochastic Oscillator
- HFFG 83.64
- CERS 50.00
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.